The NSAID dilemma: managing osteoarthritis in high-risk patients.

The Physician and sportsmedicine

Volumn 39, Issue 3, 2011, Pages 62-74

  Roth, Sanford H ^a   Anderson, Shane ^b  

^a ARIZONA STATE UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; HYALURONIC ACID; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PROTON PUMP INHIBITOR;

AGED; CARDIOVASCULAR DISEASE; CHEMICALLY INDUCED DISORDER; DRUG INTERACTION; GASTROINTESTINAL DISEASE; HUMAN; KIDNEY DISEASE; ORAL DRUG ADMINISTRATION; OSTEOARTHRITIS; PATIENT SELECTION; REVIEW; RISK; RISK FACTOR;

ACETAMINOPHEN; ADMINISTRATION, ORAL; ADRENAL CORTEX HORMONES; AGED; ANALGESICS, NON-NARCOTIC; ANALGESICS, OPIOID; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARDIOVASCULAR DISEASES; CYCLOOXYGENASE 2 INHIBITORS; DRUG INTERACTIONS; GASTROINTESTINAL DISEASES; HUMANS; HYALURONIC ACID; KIDNEY DISEASES; OSTEOARTHRITIS; PATIENT SELECTION; PROTON PUMP INHIBITORS; RISK; RISK FACTORS;

EID: 84856179182     PISSN: 00913847     EISSN: None     Source Type: Journal    
DOI: 10.3810/psm.2011.09.1922     Document Type: Review

References (0)